Featured

Wandercraft's self-balancing personal exoskeleton Eve officially launches commercially in the US

Wandercraft announced the official US commercial launch of its personal exoskeleton Eve, calling it the first FDA-cleared self-balancing personal exoskeleton that does not restrict the neurological level of spinal cord injury, allowing users to stand and perform daily activities hands-free without crutches. The access process includes clinical evaluation, a physician's prescription, individualized customization, and training; Medicare covers it under HCPCS code K1007, NSM supports delivery through more than 180 locations, and it is backed by a 16-participant training study published in JoVE.

This page provides a summary and source link only.